Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaël Schwarzinger

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Lancet. Public Health|January 9, 2022
Forecasting the prevalence of dementiaMichaël Schwarzinger, Carole Dufouil
Health and Quality of Life Outcomes|July 27, 2019
Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancerMichaël Schwarzinger, Stéphane Luchini,
Journal of Hepatology|October 4, 2021
Reply to: "Association of chronic liver disease with the prognosis of COVID-19 patients"Vincent Mallet, Michaël Schwarzinger,
The Lancet. Public Health|May 15, 2021
Addressing COVID-19 vaccine hesitancy: is official communication the key?Michaël Schwarzinger, Stéphane Luchini
Pharmacoeconomics|February 1, 2003
Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysisMichaël Schwarzinger, Bruno Housset, Fabrice Carrat
Journal of Hepatology|January 3, 2018
"Who killed JR": Chronic hepatitis C or alcohol use disorders?Michaël Schwarzinger, Jürgen Rehm, Vincent Mallet
Journal of Hepatology|March 13, 2017
Erratum to "Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study"Vincent Mallet, Kamal Hamed, Michaël Schwarzinger
Journal of Hepatology|November 10, 2016
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based studyVincent Mallet, Kamal Hamed, Michaël Schwarzinger
Journal of Health Economics|April 14, 2009
"If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoringMichaël Schwarzinger, Fabrice Carrat, Stéphane Luchini
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic evaluations of neuraminidase inhibitors to control influenzaMichaël Schwarzinger, Karine Lacombe, Fabrice Carrat
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Lancet. Public Health|January 9, 2022
Forecasting the prevalence of dementiaMichaël Schwarzinger, Carole Dufouil
Health and Quality of Life Outcomes|July 27, 2019
Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancerMichaël Schwarzinger, Stéphane Luchini,
Journal of Hepatology|October 4, 2021
Reply to: "Association of chronic liver disease with the prognosis of COVID-19 patients"Vincent Mallet, Michaël Schwarzinger,
The Lancet. Public Health|May 15, 2021
Addressing COVID-19 vaccine hesitancy: is official communication the key?Michaël Schwarzinger, Stéphane Luchini
Pharmacoeconomics|February 1, 2003
Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysisMichaël Schwarzinger, Bruno Housset, Fabrice Carrat
Journal of Hepatology|January 3, 2018
"Who killed JR": Chronic hepatitis C or alcohol use disorders?Michaël Schwarzinger, Jürgen Rehm, Vincent Mallet
Journal of Hepatology|March 13, 2017
Erratum to "Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study"Vincent Mallet, Kamal Hamed, Michaël Schwarzinger
Journal of Hepatology|November 10, 2016
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based studyVincent Mallet, Kamal Hamed, Michaël Schwarzinger
Journal of Health Economics|April 14, 2009
"If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoringMichaël Schwarzinger, Fabrice Carrat, Stéphane Luchini
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic evaluations of neuraminidase inhibitors to control influenzaMichaël Schwarzinger, Karine Lacombe, Fabrice Carrat
Pageof 6